Data as of:
brimindinvest.com / compare / syk-vs-isrgLIVE
SYK
SYK ·
$275.12
-19.08% this month
VERSUS
COMPARE
ISRG
ISRG ·
$393.33
-1.10% this month
Comparison scoreboard
ISRG LEADS 4/5
AI Scorei
SYK 49.9
ISRG 51.1
1Y Returni
SYK -27.19%
ISRG -9.75%
Fwd P/Ei
SYK 19.74
ISRG 30.87
Target Up.i
SYK +15.73%
ISRG +28.29%
Op. Margini
SYK 27.02%
ISRG 33.60%
Metrics last refreshed: 9/20/2026
Quick take

SYK vs ISRG Comparison: AI Score, Valuation, Performance and Upside

ShareXLinkedInRedditFacebookWhatsApp

Compare Stryker's broad orthopedics/MedSurg portfolio against Intuitive Surgical's da Vinci robotic-surgery platform economics.

Use this Stryker vs Intuitive Surgical comparison to evaluate the key differences across valuation, growth, profitability, and risk before making an investment decision.

Live analysis · updated 9/20/2026

ISRG holds the edge across 4 of 5 key metrics in this comparison. ISRG has delivered stronger 1-year price return (-9.75% vs -27.19%), though SYK has the better forward P/E setup (19.74x vs 30.87x for ISRG). ISRG leads on both revenue growth (18.50%) and operating margin (33.60%), suggesting a stronger fundamental setup on both dimensions. Analyst consensus implies meaningfully more upside for ISRG (+28.29%) than for SYK (+15.73%).

Want a full valuation workup? 46-section report — AI Score, Monte Carlo forecast, bull/bear case, DCF, and more.
Normalized 1Y performance
SYK
ISRG
Recent returns
SYK
ISRG
Analyst price targets & sentiment

Human Wall Street analysts' price targets, typically implying a ~12-month view — a separate signal from this site's own AI Prediction Signal further down the page, which is a 5-/30-day machine-learning forecast based on price history alone.

SYK · 28 analysts
STRONG BUYHOLDSTRONG SELL
Buy (1.9/5.0)
22 Buy / 6 Hold / 0 Sell
Price target range
analyst low$306.00
analyst high$465.00
analyst mean$382.72
current price$275.12
+15.7% upside to analyst mean
ISRG · 28 analysts
STRONG BUYHOLDSTRONG SELL
Buy (2.0/5.0)
24 Buy / 7 Hold / 1 Sell
Price target range
analyst low$350.00
analyst high$675.00
analyst mean$478.01
current price$393.33
+28.3% upside to analyst mean
Performance & AI score
Performance & AI score
MetricSYKISRG
AI scorei49.951.1
AI ranki#552#481
Latest closei$275.12$393.33
1M returni-19.08%-1.10%
6M returni-19.03%-18.04%
1Y returni-27.19%-9.75%
$10,000 invested — hypothetical growth (dividends reinvested)

How much would $10,000 be worth today if invested at the start of each period, with all dividends reinvested?

$10,000 invested — hypothetical growth (dividends reinvested)
PeriodSYKISRG
1Y ago$7.28K (-27.2%)
started 2025-09-18
$9.02K (-9.8%)
started 2025-09-18
5Y ago$11.1K (+11.0%)
started 2021-09-20
$11.64K (+16.4%)
started 2021-09-20
10Y ago$29.39K (+193.9%)
started 2016-09-19
$51.04K (+410.4%)
started 2016-09-19

Hypothetical — past performance does not guarantee future results.

Valuation & upside potential
Valuation & upside potential
MetricSYKISRG
Market capi$126.84B$133.49B
Trailing P/Ei34.2342.01
Forward P/Ei19.7430.87
Price/Salesi6.3222.91
EV/Revenuei5.3711.47
Analyst targeti$382.72$478.01
Target upsidei+15.73%+28.29%
Growth, profitability & risk
Growth, profitability & risk
MetricSYKISRG
Revenue growthi9.40%18.50%
Earnings growthi44.10%26.50%
EPS growthi+44.10%+26.50%
FCF margini+15.90%+23.70%
Operating margini27.02%33.60%
Profit margini14.43%28.45%
ROIC proxyi16.51%17.42%
Return on equityi16.51%17.42%
Dividend yieldi1.06%N/A
Payout ratioi36.06%0.00%
Dividend growth streakiNo increase yetN/A
Betai0.771.46
Debt/equityi64.390.95
Current ratioi2.164.96
Quick ratioi1.083.64
Correlation

Over the past year, SYK and ISRG have moved moderately in the same direction (correlation of 0.51), based on daily returns.

1Y
0.51
-1.0+1.0
5Y
0.63
-1.0+1.0
10Y
0.64
-1.0+1.0
Drawdown & downside risk

Lower drawdown and smaller single-period drops generally indicate a smoother ride, though they do not guarantee lower future risk.

1Y risk snapshot
SYK max drawdowni30.47%
ISRG max drawdowni44.00%
SYK max wkly dropi14.63%
ISRG max wkly dropi17.48%
5Y risk snapshot
SYK max drawdowni33.09%
ISRG max drawdowni49.90%
SYK max wkly dropi14.63%
ISRG max wkly dropi22.30%
10Y risk snapshot
SYK max drawdowni43.80%
ISRG max drawdowni49.90%
SYK max wkly dropi23.64%
ISRG max wkly dropi22.30%
Performance metrics by period
Performance metrics by period
PeriodMetricSYKISRG
1YGrowthi-27.19%-9.75%
CAGRi-27.20%-9.76%
Volatilityi29.56%36.65%
Sharpe ratioi-1.08-0.22
Sortino ratioi-1.42-0.31
Max drawdowni30.47%44.00%
Current drawdowni29.16%33.65%
Avg drawdowni11.80%18.57%
Ulcer Indexi13.94%23.03%
Max daily dropi8.81%14.15%
Max wkly dropi14.63%17.48%
5YGrowthi+6.68%+16.37%
CAGRi+1.30%+3.08%
Volatilityi25.68%34.57%
Sharpe ratioi0.000.13
Sortino ratioi0.010.19
Max drawdowni33.09%49.90%
Current drawdowni31.82%35.57%
Avg drawdowni9.04%18.07%
Ulcer Indexi11.86%22.68%
Max daily dropi8.81%14.34%
Max wkly dropi14.63%22.30%
10YGrowthi+165.27%+410.41%
CAGRi+10.25%+17.71%
Volatilityi27.02%33.15%
Sharpe ratioi0.330.52
Sortino ratioi0.470.75
Max drawdowni43.80%49.90%
Current drawdowni31.82%35.57%
Avg drawdowni6.99%12.04%
Ulcer Indexi10.01%17.10%
Max daily dropi13.11%14.34%
Max wkly dropi23.64%22.30%
AI Prediction Signali
Members only
Next 5 trading days
SYK
+2.8%BUY
ISRG
+1.1%HOLD
Next 30 trading days
SYK
+6.4%BUY
ISRG
+3.2%HOLD

Sign up to unlock AI price predictions

ML model trained on historical prices · 14-day free trial · No credit card required
Business comparison
Business comparison
CategorySYKISRG
CompanySYKISRG
SectorHealthcareHealthcare
IndustryMedical DevicesMedical Instruments & Supplies
Core businessStryker Corporation operates as a medical technology company in the United States and internationally.Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationa…
Free public comparison

Want deeper AI forecasts?

This comparison page is public and free forever. Subscribers can unlock saved watchlists, full AI rankings, detailed forecasts, and interactive analysis tools.

In-Depth Reports

Full valuation workup with AI Score, Monte Carlo forecast, and bull/bear case — free preview, premium data from $3.99.

Related comparisons
More comparisons
Browse all 1,000 comparisons
ShareXLinkedInRedditFacebookWhatsApp